ArticleThe Journal of pharmacology and experimental therapeutics2025

NOSH-aspirin (NBS-1120) inhibits estrogen receptor-negative breast cancer in vitro and in vivo by modulating redox-sensitive signaling pathways.

Mitali Chattopadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.